Skriver, Signe Korsgaard http://orcid.org/0000-0003-1895-0963
Jensen, Maj-Britt
Knoop, Ann Soegaard
Ejlertsen, Bent
Laenkholm, Anne-Vibeke
Funding for this research was provided by:
Kræftens Bekæmpelse (R146-A9562)
Article History
Received: 5 February 2020
Accepted: 29 April 2020
First Online: 14 May 2020
Ethics approval and consent to participate
: All patients provided written informed consent, and the Biomedical Research Ethics of the Danish Capital Region approved the protocol (H-15012740).
: Not applicable.
: SKS: none. MBJ: <i>Nanostring Technologies, Inc.</i> (grant: institutional) and <i>Oncology venture</i> (grant: institutional). ASK: <i>Roche</i> (grant: institutional). Ad Board: <i>Novartis</i>, <i>Astra Zeneca</i>, <i>MDS, Roche</i>, <i>Pfizer</i>, and <i>ELI LILLY DANMARK A/S</i>. BE: <i>Nanostring Technologies, Inc.</i> (grant: institutional), <i>Novartis</i> (grant: institutional), and <i>Roche</i> (grant: institutional). AVL: <i>Nanostring Technologies, Inc.</i> (grant) and <i>Roche</i> (grant).